| Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines S Black, J Eskola, CA Siegrist, N Halsey, N MacDonald, B Law, E Miller, ... The Lancet 374 (9707), 2115-2122, 2009 | 309 | 2009 |
| Long-term risk of tuberculosis among foreign-born persons in the United States PLF Zuber, MT McKenna, NJ Binkin, IM Onorato, KG Castro Jama 278 (4), 304-307, 1997 | 309 | 1997 |
| Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines B Keller-Stanislawski, JA Englund, G Kang, P Mangtani, K Neuzil, ... Vaccine 32 (52), 7057-7064, 2014 | 254 | 2014 |
| Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67 P Zuber, MF Hamou, N de Tribolet Neurosurgery 22 (2), 364-368, 1988 | 166 | 1988 |
| Transforming growth factor‐β2 down‐regulates HLA‐DR antigen expression on human malignant glioma cells. P Zuber, MC Kuppner, ND Tribolet European journal of immunology 18 (10), 1623-1626, 1988 | 135 | 1988 |
| Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience MH Djingarey, R Barry, M Bonkoungou, S Tiendrebeogo, R Sebgo, ... Vaccine 30, B40-B45, 2012 | 127 | 2012 |
| Overseas screening for tuberculosis in immigrants and refugees to the United States: current status NJ Binkin, PLF Zuber, CD Wells, MA Tipple, KG Castro Clinical infectious diseases 23 (6), 1226-1232, 1996 | 120 | 1996 |
| International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines CN Dodd, SA Romio, S Black, C Vellozzi, N Andrews, M Sturkenboom, ... Vaccine 31 (40), 4448-4458, 2013 | 112 | 2013 |
| Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use AE Tozzi, EJ Asturias, MR Balakrishnan, NA Halsey, B Law, PLF Zuber Vaccine 31 (44), 5041-5046, 2013 | 110 | 2013 |
| Global alignment of immunization safety assessment in pregnancy–the GAIA project J Bonhoeffer, S Kochhar, S Hirschfeld, PT Heath, CE Jones, J Bauwens, ... Vaccine 34 (49), 5993-5997, 2016 | 97 | 2016 |
| The public health value of vaccines beyond efficacy: methods, measures and outcomes A Wilder-Smith, I Longini, PL Zuber, T Bärnighausen, WJ Edmunds, ... BMC medicine 15, 1-9, 2017 | 94 | 2017 |
| Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand AN Do, K Limpakarnjarat, W Uthaivoravit, PLF Zuber, S Korattana, ... The International Journal of Tuberculosis and Lung Disease 3 (5), 377-381, 1999 | 91 | 1999 |
| Intussusception and rotavirus vaccination: a review of the available evidence MM Patel, P Haber, J Baggs, P Zuber, JE Bines, UD Parashar Expert review of vaccines 8 (11), 1555-1564, 2009 | 89 | 2009 |
| Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Cote d'Ivoire S Kassim, P Zuber, SZ Wiktor, FVK Diomande, IM Coulibaly, D Coulibaly, ... The International Journal of Tuberculosis and Lung Disease 4 (4), 321-326, 2000 | 88 | 2000 |
| Impact of wastage on single and multi-dose vaccine vials: implications for introducing pneumococcal vaccines in developing countries D Parmar, EM Baruwa, P Zuber, S Kone Human vaccines 6 (3), 270-278, 2010 | 87 | 2010 |
| Immunization stress-related response–redefining immunization anxiety-related reaction as an adverse event following immunization MS Gold, NE MacDonald, CM McMurtry, MR Balakrishnan, U Heininger, ... Vaccine 38 (14), 3015-3020, 2020 | 81 | 2020 |
| Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS B Autran, EJ Asturias, S Evans, K Hartigan-Go, G Hussey, TJ John, ... Expert review of vaccines 8 (6), 705-716, 2009 | 75 | 2009 |
| Tuberculosis prevention among foreign-born persons in Seattle–King County, Washington CD Wells, PLF Zuber, CM Nolan, NJ Binkin, SV Goldberg American journal of respiratory and critical care medicine 156 (2), 573-577, 1997 | 72 | 1997 |
| Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015 J Lei, MR Balakrishnan, JF Gidudu, PLF Zuber Vaccine 36 (12), 1577-1582, 2018 | 65 | 2018 |
| Enhancing vaccine safety capacity globally: A lifecycle perspective RT Chen, TT Shimabukuro, DB Martin, PLF Zuber, DM Weibel, ... Vaccine 33, D46-D54, 2015 | 62 | 2015 |
